Gal-3, a pro-angiogenic lectin, was increased in mouse and human samples with TSC2 deficiency and Gal-3 serum levels correlated with LAM severity and the presence of AMLs in a cohort of patients with LAM. Here, LGALS3 is linked to lymphangioleiomyomatosis.